While the United Nations have designated 2024 as the International Year of Camelids, it seems fitting to focus on a little-known peculiarity of the immune system of camels, dromedaries, llamas and their relatives, which has sparked the development of a new class of therapeutics.
Exciting Discoveries
In humans as well as in all non-camelid mammals, antibodies are relatively large molecules made up of two heavy and two light chains, and it was long believed that both heavy and light chains are required for antigen binding. In camelids, however, up to 80 % of antibodies completely lack the light chains yet bind to antigens just as strongly as their larger cousins. The discovery of heavy-chain-only immunoglobulins in dromedaries, soon dubbed camelbodies, in the early 1990s led to the development of increasingly smaller single domain immunoglobulins, the smallest of which are called nanobodies and have a size of only 10% of a human immunoglobulin. Their small size and single domain structure on the one hand make them ideally suited for large-scale production in bacterial cells and on the other hand allow them to penetrate tissues and cells much more readily than a full-size antibody.
Heavy-chain only antibodies with variable domains colored light purple and conventional immunoglobulins with variable domains colored light green against red background
Therapeutic antibodies derived from camelids
For a time in the late 1990s and early 2000s, biotechnologists were very keen to collaborate with veterinary institutes that had a herd of dromedaries, camels or llamas, allowing them to generate specific camelbodies by immunizing the animals with a target molecule. In the meantime, numerous camelbody cDNA libraries exist which allow the generation of novel types of nanobodies without a live camel.
To date, single domain antibodies derived from camelids have been used as diagnostic tools, imaging probes, as well as therapeutics that can be inhaled or taken orally − routes that are often not available to conventional therapeutic antibodies.
- Handbook of Therapeutic Antibodies, 2nd Edition, edited by Stefan Dübel & Janice M. Reichert, ISBN 978-3-527-68244-7
- Medicine and Surgery of Camelids, 4th Edition, edited by Andrew J. Niehaus, ISBN 978-1-119-58324-0
Robert Koch, der Tuberkulin-Skandal und andere Irrtümer großer Wissenschaftler
Robert Koch zählt zu den bedeutendsten Medizinern des 19. Jahrhunderts. Mit der Entdeckung des Milzbranderregers (Bacillus anthracis) und der Isolierung des Tuberkulosebakteriums (Mycobacterium tuberculosis) legte er den Grundstein für die moderne Bakteriologie. Auch...
Der längste Kohlenwasserstoff der Welt – und warum das überhaupt spannend ist
Stell dir vor, du baust mit LEGO – aber nicht irgendeine Form, sondern eine Kette aus sage und schreibe 1172 winzigen Bausteinen, die alle exakt gleich aussehen. Willkommen in der Welt der Alkane! Alkane sind Stoffe, die nur aus Kohlen- und Wasserstoffatomen bestehen....
Die Kettenlinie – wenn Physik elegant durchhängt
Stell dir vor, du hältst ein Seil in beiden Händen und lässt es locker durchhängen. Was du da vor deinem geistigen Auge siehst, ist keine Parabel – auch wenn es auf den ersten Blick den Anschein hat. Es ist eine Kettenlinie; eine Form, die sich ganz natürlich ergibt,...
Eiswürfel & Physik: Warum es Frühaufsteher leichter haben
Wer schon einmal versucht hat, an einem heißen Sommertag eine große Menge Eiswürfel zu bereiten, wird vielleicht bemerkt haben, dass der Gefrierschrank für die gleiche Menge an Eiswürfeln umso länger laufen muss, je heißer es draußen ist. Es ist doch klar, dass ich...